Sai, Centrix & Agility Form Integrated CMC Partnership

Today, Centrix Pharma Solutions, Sai Life Sciences, and Agility Life Sciences announced the formation of an Integrated CMC Partnership aimed at offering innovative biopharma firms comprehensive Chemistry, Manufacturing, and Controls (CMC) services.

The partnership brings together the vast CMC experience of Centrix Pharma Solutions in medicinal product development and clinical production, Sai Life Sciences in API development, and Agility Life Sciences in formulation development.

Customers will benefit from integrated drug substances and drug product development through this cooperation, which will facilitate their smooth transition from preclinical research to first-in-human (FIH) clinical trials and beyond.

Also Read: Terumo India Launches FineCross M3 in Cardiology Portfolio

In terms of revenue CAGR and EBITDA CAGR from FY22 to FY24, Sai Life Sciences is the contract research, development, and manufacturing organization (CRDMO) with the greatest rate of growth among its listed Indian peers. We collaborate with more than 280 innovative pharmaceutical and biotech businesses worldwide as a pure-play, full-service CRDMO to expedite their NCE small molecule programs' discovery, development, and commercialization.

Sai Life Sciences has provided services for a variety of programs over the last 25 years, continuously delivering value based on its responsiveness and quality. We employed 2845 people at our facilities in India, the UK, the USA, and Japan as of March 2024.